Novo Nordisk A/S (BKK:NOVOB80)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of THB 6.80 trillion. The enterprise value is 7.14 trillion.

Market Cap	6.80T
Enterprise Value	7.14T

Important Dates

The last earnings date was Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	Aug 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.46%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	29.88%
Float	3.19B

Valuation Ratios

The trailing PE ratio is 12.84 and the forward PE ratio is 12.30.

PE Ratio	12.84
Forward PE	12.30
PS Ratio	4.22
PB Ratio	7.84
P/TBV Ratio	21.05
P/FCF Ratio	20.20
P/OCF Ratio	10.76
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.52, with an EV/FCF ratio of 21.22.

EV / Earnings	13.49
EV / Sales	4.51
EV / EBITDA	8.52
EV / EBIT	9.26
EV / FCF	21.22

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.60.

Current Ratio	0.78
Quick Ratio	0.53
Debt / Equity	0.60
Debt / EBITDA	0.61
Debt / FCF	1.53
Interest Coverage	19.21

Financial Efficiency

Return on equity (ROE) is 71.46% and return on invested capital (ROIC) is 42.81%.

Return on Equity (ROE)	71.46%
Return on Assets (ROA)	21.11%
Return on Invested Capital (ROIC)	42.81%
Return on Capital Employed (ROCE)	55.29%
Revenue Per Employee	20.50M
Profits Per Employee	6.74M
Employee Count	77,349
Asset Turnover	0.69
Inventory Turnover	1.22

Taxes

In the past 12 months, Novo Nordisk has paid 143.55 billion in taxes.

Income Tax	143.55B
Effective Tax Rate	21.33%

Stock Price Statistics

The stock price has decreased by -57.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-57.42%
50-Day Moving Average	1.76
200-Day Moving Average	2.20
Relative Strength Index (RSI)	37.92
Average Volume (20 Days)	6,041,821

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of THB 1.61 trillion and earned 529.41 billion in profits. Earnings per share was 119.03.

Revenue	1.61T
Gross Profit	1.34T
Operating Income	783.88B
Pretax Income	672.96B
Net Income	529.41B
EBITDA	844.28B
EBIT	783.88B
Earnings Per Share (EPS)	119.03

Balance Sheet

The company has 166.22 billion in cash and 516.35 billion in debt, giving a net cash position of -350.13 billion.

Cash & Cash Equivalents	166.22B
Total Debt	516.35B
Net Cash	-350.13B
Net Cash Per Share	n/a
Equity (Book Value)	866.74B
Book Value Per Share	195.06
Working Capital	-267.71B

Cash Flow

In the last 12 months, operating cash flow was 631.49 billion and capital expenditures -294.93 billion, giving a free cash flow of 336.56 billion.

Operating Cash Flow	631.49B
Capital Expenditures	-294.93B
Free Cash Flow	336.56B
FCF Per Share	n/a

Margins

Gross margin is 83.44%, with operating and profit margins of 48.69% and 32.88%.

Gross Margin	83.44%
Operating Margin	48.69%
Pretax Margin	41.80%
Profit Margin	32.88%
EBITDA Margin	52.44%
EBIT Margin	48.69%
FCF Margin	20.90%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 2.60%.

Dividend Per Share	0.04
Dividend Yield	2.60%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	49.88%
Buyback Yield	0.46%
Shareholder Yield	3.05%
Earnings Yield	7.79%
FCF Yield	4.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novo Nordisk has an Altman Z-Score of 6.16 and a Piotroski F-Score of 4.

Altman Z-Score	6.16
Piotroski F-Score	4